
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BIJUVA | Mayne Group | N-210132 RX | 2018-10-28 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ESTROGEL | Ascend Therapeutics | N-021166 RX | 2004-02-09 | 1 products, RLD, RS |
| CLIMARA | Bayer | N-020375 RX | 1994-12-22 | 6 products, RLD, RS |
| MENOSTAR | Bayer | N-021674 RX | 2004-06-08 | 1 products, RLD, RS |
| IMVEXXY | Mayne Group | N-208564 RX | 2018-05-29 | 2 products, RLD, RS |
| MINIVELLE | Noven Pharmaceuticals | N-203752 RX | 2012-10-29 | 5 products, RLD, RS |
| VAGIFEM | Novo Nordisk | N-020908 RX | 2009-11-25 | 1 products, RLD, RS |
| EVAMIST | Padagis | N-022014 RX | 2007-07-27 | 1 products, RLD, RS |
| ESTRING | Pfizer | N-020472 RX | 1996-04-26 | 1 products, RLD, RS |
| VIVELLE-DOT | Sandoz | N-020538 RX | 1999-01-08 | 5 products, RLD, RS |
| DIVIGEL | Vertical Pharmaceuticals | N-022038 RX | 2007-06-04 | 5 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ACTIVELLA | Amneal Pharmaceuticals | N-020907 RX | 1998-11-18 | 1 products, RLD, RS |
| COMBIPATCH | Noven Pharmaceuticals | N-020870 RX | 1998-08-07 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| FEMRING | Millicent Pharma | N-021367 RX | 2003-03-20 | 2 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| MYFEMBREE | Myovant Sciences | N-214846 RX | 2021-05-26 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DEPO-TESTADIOL | Pharmacia & Upjohn | N-017968 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LUNELLE | Pharmacia & Upjohn | N-020874 DISCN | 2000-10-05 | 1 products, RLD |
Brand Name | Status | Last Update |
|---|---|---|
| 3.6oz biest 2.5 estrogen cream | unapproved drug other | 2025-06-01 |
| abigale abigale lo | ANDA | 2024-09-17 |
| activella | New Drug Application | 2023-11-30 |
| afirmelle | ANDA | 2025-08-01 |
| altavera | ANDA | 2023-03-02 |
| alyacen 1/35 | ANDA | 2024-05-07 |
| alyacen 1/35 alyacen 7/7/7 | ANDA | 2017-09-08 |
| alyacen 7/7/7 | ANDA | 2023-06-07 |
| amethia | ANDA | 2024-03-01 |
| amethyst | ANDA | 2022-01-31 |
Expiration | Code | ||
|---|---|---|---|
ESTRADIOL / NORETHINDRONE ACETATE / RELUGOLIX, MYFEMBREE, MYOVANT SCIENCES | |||
| 2026-01-27 | M-289 | ||
| 2025-12-18 | NCE | ||
| 2025-08-05 | I-898 | ||
| 2024-05-26 | NP | ||
ESTRADIOL, ESTRADIOL, CHEMO RESEARCH SL | |||
| 2023-04-08 | CGT | ||
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Estradiol / Norethindrone Acetate / Relugolix, Myfembree, Myovant Sciences | |||
| 11033551 | 2037-09-29 | U-3129 | |
| 9346822 | 2024-02-17 | U-3129 | |
| 7300935 | 2024-01-28 | DP | |
| 8058280 | 2024-01-28 | DP | |
| Estradiol, Imvexxy, Mayne Pharma | |||
| 11266661 | 2034-02-02 | U-2316, U-2317 | |
| 9180091 | 2033-12-20 | DP | U-2316, U-2317 |
| 10258630 | 2033-12-20 | U-2316, U-2317 | |
| 10398708 | 2033-12-20 | U-2317, U-2614 | |
| 10471072 | 2033-06-18 | U-2316, U-2317 | |
| 10568891 | 2033-06-18 | U-2316, U-2317 | |
| 10668082 | 2033-06-18 | U-2316, U-2317 | |
| 10888516 | 2033-06-18 | U-2316, U-2317 | |
| 11065197 | 2033-06-18 | DP | |
| 11116717 | 2033-06-18 | DP | |
| 11123283 | 2033-06-18 | DP | |
| 9289382 | 2032-11-21 | DP | |
| 10537581 | 2032-11-21 | DP | U-2316, U-2317 |
| 10806697 | 2032-11-21 | DP | |
| 10835487 | 2032-11-21 | U-2316, U-2317 | |
| 11241445 | 2032-11-21 | U-2316, U-2317 | |
| 11246875 | 2032-11-21 | U-2316, U-2317 | |
| 11304959 | 2032-11-21 | DP | |
| 11351182 | 2032-11-21 | U-2316, U-2317 | |
| 11497709 | 2032-11-21 | U-2316, U-2317 | |
| Estradiol / Progesterone, Bijuva, Mayne Pharma | |||
| 8633178 | 2032-11-21 | DP | |
| 8846648 | 2032-11-21 | U-2439 | |
| 8846649 | 2032-11-21 | DP | U-2439 |
| 8933059 | 2032-11-21 | DP | U-2439 |
| 8987237 | 2032-11-21 | DP | |
| 8993548 | 2032-11-21 | DP | |
| 8993549 | 2032-11-21 | DP | |
| 9006222 | 2032-11-21 | DP | U-2439 |
| 9114145 | 2032-11-21 | U-2439 | |
| 9114146 | 2032-11-21 | DP | U-2439 |
| 9301920 | 2032-11-21 | DP | U-2439 |
| 10052386 | 2032-11-21 | DP | |
| 10206932 | 2032-11-21 | U-2439 | |
| 10639375 | 2032-11-21 | DP | |
| 10675288 | 2032-11-21 | U-2439 | |
| 10806740 | 2032-11-21 | DP | U-2439 |
| 11033626 | 2032-11-21 | DP | U-2439 |
| 11103513 | 2032-11-21 | U-2439 | |
| 11103516 | 2032-11-21 | DP | |
| 11110099 | 2032-11-21 | DP | |
| 11166963 | 2032-11-21 | DP | |
| 11529360 | 2032-11-21 | DP | |
| Drospirenone / Estradiol, Angeliq, Bayer Hlthcare | |||
| 8906890 | 2031-10-22 | DP | |
| Estradiol, Minivelle, Noven | |||
| 8231906 | 2030-07-04 | DS, DP | |
| 9724310 | 2028-07-10 | DS, DP | |
| 9730900 | 2028-07-10 | U-2086 | |
| 9833419 | 2028-07-10 | DP | |
| Dienogest / Estradiol Valerate, Natazia, Bayer Hlthcare | |||
| 8153616 | 2028-01-30 | U-1240 | |
| 8071577 | 2026-05-13 | DP | U-1 |
| Estradiol Acetate, Femtrace, Apil | |||
| 7572779 | 2025-10-02 | U-904 | |
Code | Description |
|---|---|
| A9591 | Fluoroestradiol f 18, diagnostic, 1 millicurie |
| J1000 | Injection, depo-estradiol cypionate, up to 5 mg |
| J1380 | Injection, estradiol valerate, up to 10 mg |
| J7294 | Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Menopause | D008593 | EFO_0003922 | N95 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Atrophy | D001284 | — | — | — | — | 1 | — | — | 1 |
| Vaginitis | D014627 | EFO_0005757 | N76 | — | — | 1 | — | — | 1 |
| Atrophic vaginitis | D059268 | EFO_1001271 | — | — | — | 1 | — | — | 1 |
| Drug common name | Estradiol |
| INN | estradiol valerate |
| Description | 17beta-estradiol is the 17beta-isomer of estradiol. It has a role as an estrogen, a human metabolite, an EC 1.2.3.1 (aldehyde oxidase) inhibitor, a Daphnia magna metabolite, a mouse metabolite and a geroprotector. It is a 17beta-hydroxy steroid and an estradiol. |
| Classification | Small molecule |
| Drug class | estrogens |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O |
| PDB | — |
| CAS-ID | 50-28-2 |
| RxCUI | — |
| ChEMBL ID | CHEMBL135 |
| ChEBI ID | 16469 |
| PubChem CID | 5757 |
| DrugBank | DB00783 |
| UNII ID | 4TI98Z838E (ChemIDplus, GSRS) |



































































